December 2012 Newsletter

December 20, 2012:

Q3-2012 IVT Injection Growth Slows

Total US retinal procedure volume topped an estimated 1.1 million in Q3-2012, but the rate of growth for IVT treatments failed to keep pace with previous quarters.

December 20, 2012:

Use of Alternative Glaucoma Treatments Grows Significantly

Our latest quarterly glaucoma survey indicates a significant increase in the use of the Alcon ExPress, Glaukos iStent, and other alternatives to conventional filtering surgery during the quarter.

December 20, 2012:

Growth Expected in Highly Competitive Retinal and Glaucoma Laser Market

The market for photocoagulation, photodisruptor, and SLT lasers is lucrative, with sales estimated at more than $345 million in 2012.

December 20, 2012:

Appeals Court Vacates Conviction Involving Promotion of Drugs for Off-label Uses

A federal appeals court has added more confusion to the process of off-label drug use by ruling that pharmaceutical companies and their employees can’t be prosecuted for promoting drugs for unapproved uses.

December 20, 2012:

December 2012 News Briefs

Social media